通过优化mRNA和传递载体来解锁mRNA驱动的CRISPR-Cas9基因疗法
Shengyi Wang1,2,3, Xiaoyu Xu2,3,4,5, Tapani Viitala3,6
1Joint Centre of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325015, China.
Molecular therapy. Nucleic acids
|November 10, 2025
概括
由信使RNA (mRNA) 驱动的CRISPR-Cas9基因疗法可以在没有基因组整合的情况下提供高效的编辑. 本综述涵盖了mRNA稳定性,传递和新型基因编辑器的进展,以克服临床挑战.
科学领域:
- 分子生物学分子生物学
- 基因治疗 基因治疗
- 生物技术是生物技术.
背景情况:
- 基于mRNA的CRISPR-Cas9基因疗法对高效的基因组编辑有希望.
- 目前的限制包括mRNA不稳定性,免疫性,短半衰期和低效的体内输送.
- 非目标效应也对临床应用构成重大挑战.
研究的目的:
- 审查mRNA驱动的CRISPR-Cas9基因疗法的最新进展.
- 突出提高mRNA稳定性和翻译效率的策略.
- 讨论新的传递载体和基因编辑工具.
主要方法:
- 关于基于mRNA的基因编辑的最新研究的文献综述.
- 对CRISPR-Cas9和原始编辑技术的进展进行分析.
- 检查用于mRNA治疗的新型输送系统.
主要成果:
- 在提高mRNA稳定性和翻译效率方面取得了进展.
- 新的传递载体正在开发中,以增强体内传递.
- 新的基因编辑器和主要编辑技术显示出提高准确性和效率的潜力.
结论:
- 克服mRNA稳定性,分发和特异性的挑战对于临床翻译至关重要.
- 基因编辑工具和传递系统的持续创新将推动基于mRNA的疗法.
- 本综述为mRNA驱动的CRISPR-Cas9疗法提供了当前景观和未来方向的全面概述.
相关概念视频
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K


